avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa4
|
ENSMUSG00000000942.10 | homeobox A4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxa4 | mm10_v2_chr6_-_52191695_52191753 | -0.52 | 1.3e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
2.2 | 13.4 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.7 | 3.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.4 | 4.1 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
1.1 | 5.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 5.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.8 | 13.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 2.4 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.7 | 6.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.6 | 3.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.6 | 6.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.6 | 1.7 | GO:0021759 | globus pallidus development(GO:0021759) |
0.5 | 2.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.5 | 1.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.3 | GO:0002465 | CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment(GO:0002362) peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) negative regulation of histone deacetylation(GO:0031064) negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.4 | 1.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.4 | 2.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 2.8 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
0.3 | 1.0 | GO:0002194 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.3 | 1.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 1.8 | GO:0060011 | Sertoli cell proliferation(GO:0060011) prostate epithelial cord elongation(GO:0060523) |
0.3 | 1.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 2.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 1.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 2.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 1.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 1.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 1.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 1.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 2.2 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.2 | 0.9 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 1.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 1.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 1.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.9 | GO:0051684 | maintenance of centrosome location(GO:0051661) maintenance of Golgi location(GO:0051684) |
0.2 | 2.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.6 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.1 | 2.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 2.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 2.6 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.1 | 0.3 | GO:0046166 | alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.3 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 1.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 1.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.4 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 1.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.3 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.1 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 1.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.1 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.1 | 3.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.4 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 1.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 3.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 1.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0035166 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) post-embryonic hemopoiesis(GO:0035166) |
0.1 | 1.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 1.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 2.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 2.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.2 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 1.0 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.0 | 0.8 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 2.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 1.1 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 1.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 6.0 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 1.0 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 1.1 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 1.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.9 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 3.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 1.1 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 2.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 1.5 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.9 | GO:2000242 | negative regulation of reproductive process(GO:2000242) |
0.0 | 0.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 1.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.0 | 0.7 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 3.2 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.7 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 7.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.5 | 13.4 | GO:0042567 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.3 | 1.5 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 0.6 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 1.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 2.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 1.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 2.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 4.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 2.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 4.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 2.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 3.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 1.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 2.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 3.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 3.8 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 1.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 3.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 2.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 2.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:0046911 | metal chelating activity(GO:0046911) |
1.9 | 13.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.1 | 5.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.1 | 3.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 4.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 6.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 1.8 | GO:0038052 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.5 | 1.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.5 | 2.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 2.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 1.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 2.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 9.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.3 | 9.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.3 | 1.0 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.3 | 2.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 1.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.9 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 1.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 5.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.2 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 4.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 1.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 2.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 3.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 2.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 1.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 1.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 1.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 3.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 1.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 1.8 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 1.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 2.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 7.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 2.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.8 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 15.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 12.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 8.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 5.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 4.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 3.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 4.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 6.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 7.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 3.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 8.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 5.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 4.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 3.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 1.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 1.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 3.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 2.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |